Alligator Bioscience AB (ATORX) — Strategic Asset Allocation Index
Alligator Bioscience AB (ATORX) has a Strategic Asset Allocation Index of 27.3% as of December 2025. Strategic assets (PP&E of Skr1.87 Million plus long-term investments of Skr-) total Skr1.87 Million, measured against net assets of Skr6.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Alligator Bioscience AB liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Alligator Bioscience AB Strategic Asset Allocation Index (2005–2025)
This chart shows how Alligator Bioscience AB's Strategic Asset Allocation Index has evolved across 17 annual periods from 2005 to 2025. As of December 2025, the index stands at 27.3%, representing strategic assets of Skr1.87 Million against net assets of Skr6.86 Million SEK. See ATORX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Alligator Bioscience AB (2005–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Alligator Bioscience AB from 2005 to 2025, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Alligator Bioscience AB.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.3% | Skr1.87 Million | Skr1.87 Million | Skr- | Skr6.86 Million | ▼ -144.0 pp |
| 2023 | 171.3% | Skr20.31 Million | Skr20.31 Million | Skr- | Skr11.86 Million | ▲ +141.1 pp |
| 2022 | 30.2% | Skr26.94 Million | Skr26.94 Million | Skr- | Skr89.05 Million | ▲ +24.8 pp |
| 2021 | 5.5% | Skr15.42 Million | Skr15.42 Million | Skr- | Skr282.27 Million | ▼ -14.7 pp |
| 2020 | 20.2% | Skr23.24 Million | Skr23.24 Million | Skr- | Skr115.24 Million | ▼ -13.3 pp |
| 2019 | 33.5% | Skr86.49 Million | Skr33.48 Million | Skr53.02 Million | Skr258.50 Million | ▲ +18.2 pp |
| 2018 | 15.3% | Skr71.50 Million | Skr18.24 Million | Skr53.26 Million | Skr468.31 Million | ▲ +0.7 pp |
| 2017 | 14.6% | Skr90.32 Million | Skr16.20 Million | Skr74.12 Million | Skr617.96 Million | ▲ +14.0 pp |
| 2016 | 0.6% | Skr4.35 Million | Skr4.35 Million | Skr- | Skr676.18 Million | ▲ +0.0 pp |
| 2015 | 0.6% | Skr2.42 Million | Skr2.32 Million | Skr95.00K | Skr396.97 Million | ▼ -2.8 pp |
| 2014 | 3.4% | Skr2.31 Million | Skr2.31 Million | Skr- | Skr68.52 Million | ▼ -2.0 pp |
| 2011 | 5.4% | Skr1.15 Million | Skr1.15 Million | Skr- | Skr21.51 Million | ▼ -123.5 pp |
| 2010 | 128.9% | Skr1.46 Million | Skr1.46 Million | Skr- | Skr1.13 Million | ▲ +106.4 pp |
| 2008 | 22.4% | Skr2.82 Million | Skr2.82 Million | Skr- | Skr12.57 Million | ▲ +17.8 pp |
| 2007 | 4.6% | Skr1.93 Million | Skr1.93 Million | Skr- | Skr41.44 Million | ▼ -11.0 pp |
| 2006 | 15.7% | Skr1.71 Million | Skr1.71 Million | Skr- | Skr10.91 Million | ▼ -62.9 pp |
| 2005 | 78.6% | Skr2.54 Million | Skr2.54 Million | Skr- | Skr3.23 Million | — |